Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IMPDH1 | P20839 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | FNTA | P49354 | 4/20 | 0.32 |
| ▸ | FNTB | P49356 | 4/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | ATP1A1 | P05023 | 1/20 | 0.32 |
| ▸ | ATP1B1 | P05026 | 1/20 | 0.32 |
| ▸ | ATP1A3 | P13637 | 1/20 | 0.32 |
| ▸ | ATP1B2 | P14415 | 1/20 | 0.32 |
| ▸ | ATP1A2 | P50993 | 1/20 | 0.32 |
| ▸ | ATP1B3 | P54709 | 1/20 | 0.32 |
| ▸ | FXYD2 | P54710 | 1/20 | 0.32 |
| ▸ | ATP1A4 | Q13733 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10359555 | 1.00 | IMPDH1 (0.36) | IMPDH1NPC1FNTAFNTBPTGS1 | |
| SCHEMBL10359313 | 0.91 | PTGS1 (0.34) | IMPDH1FNTAFNTBPTGS1 | |
| SCHEMBL10359299 | 0.84 | TSHR (0.33) | — | |
| SCHEMBL14291719 | 0.69 | CYP3A4 (0.31) | — | |
| SCHEMBL17453508 | 0.69 | CYP3A4 (0.31) | — | |
| SCHEMBL2240425 | 0.69 | CYP3A4 (0.31) | — | |
| SCHEMBL10359748 | 0.68 | PPARG (0.39) | PTGS1 | |
| SCHEMBL2471005 | 0.60 | — | — | |
| SCHEMBL25292269 | 0.59 | NPC1 (0.33) | NPC1FNTAFNTB | |
| SCHEMBL7495347 | 0.59 | MME (0.39) | NPC1FNTAFNTBPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0213547-B1 | CYCLOHEXANEALKANOIC ACIDS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1990-12-27 | — | — | EP | claimed |